|
ELTX Elicio Therapeutics Inc 1601485 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-11,823,000.00 |
| Balance Sheet |
|
Current Assets
|
$16,200,000.00 |
|
Assets
|
$22,689,000.00 |
|
Current Liabilities
|
$7,229,000.00 |
|
Liabilities
|
$24,126,000.00 |
|
Equity
|
$-1,437,000.00 |
|
Shares Out
|
18639895.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-11,645,000.00 |
|
Investing Cash Flow
|
$-16,000.00 |
| Market Analysis |
Market Cap
|
$54,242,094.45 |
|
Price
|
$2.84 |
|
PB
|
4.68 |
|
EPS
|
-0.65 |
|
FCF
|
$-11,661,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:36 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ELTX documents filed with the SEC.
ELTX Filings
Clear
